The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10x Genomics, Inc. | CL A COM | 88025u109 | 13,755 | 303,984 | SH | SOLE | 303,984 | 0 | 0 | ||
| 908 Devices Inc. | COM | 65443P102 | 412 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| Aadi Bioscience, Inc. | COM | 00032Q104 | 6,484 | 526,329 | SH | SOLE | 526,329 | 0 | 0 | ||
| Adicet Bio, Inc. | COM | 007002108 | 8,468 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| Albireo Pharma, Inc. | COM | 01345P106 | 10,294 | 518,342 | SH | SOLE | 518,342 | 0 | 0 | ||
| Alpine Immune Sciences, Inc. | COM | 02083G100 | 40,068 | 4,708,288 | SH | SOLE | 4,708,288 | 0 | 0 | ||
| Arcus BioSciences, Inc. | COM | 03969f109 | 22,040 | 869,790 | SH | SOLE | 869,790 | 0 | 0 | ||
| AtriCure Inc. | COM | 004963C20 | 1,890 | 46,259 | SH | SOLE | 46,259 | 0 | 0 | ||
| Aura Biosciences, Inc. | COM | 05153U107 | 2,976 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| BeyondSpring Inc. | SHS | G10830100 | 7,140 | 4,958,142 | SH | SOLE | 4,958,142 | 0 | 0 | ||
| Cue Health Inc. | COM | 229790100 | 28,739 | 8,980,909 | SH | SOLE | 8,980,909 | 0 | 0 | ||
| Equillium Inc. | COM | 29446K106 | 9,073 | 4,447,308 | SH | SOLE | 4,447,308 | 0 | 0 | ||
| Horizon Therapeutics PLC | COM | G46188101 | 4,419 | 55,400 | SH | SOLE | 55,400 | 0 | 0 | ||
| Illumnia, Inc. | COM | 452327109 | 28,435 | 154,238 | SH | SOLE | 154,238 | 0 | 0 | ||
| Mersana Therapeutics, Inc. | COM | 59045L106 | 4,178 | 904,268 | SH | SOLE | 904,268 | 0 | 0 | ||
| Nautilus Biotechnology, Inc. | COM | 63909J108 | 807 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| NeuBase Therapeutics, Inc. | COM | 64132K102 | 1,050 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Owlet, Inc. | COM CL A | 69120X107 | 1,527 | 898,400 | SH | SOLE | 898,400 | 0 | 0 | ||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | 6,470 | 1,463,872 | SH | SOLE | 1,463,872 | 0 | 0 | ||
| Prometheus Biosciences, Inc. | COM | 74349U108 | 7,058 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| Scynexis Inc. | COM NEW | 811292200 | 1,033 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | ||
| Sema4 Holings Corp. | COM CL A | 81663L101 | 4,308 | 3,418,929 | SH | SOLE | 3,418,929 | 0 | 0 | ||
| Singular Genomics Systems, Inc. | COM | 82933R100 | 76 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| Terns Pharmaceuticals, Inc. | COM | 880881107 | 1,771 | 714,285 | SH | SOLE | 714,285 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 51,271 | 1,824,583 | SH | SOLE | 1,824,583 | 0 | 0 | ||